Amreen M Dinani (Amreen Dinani)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Glycemic Control

Top Venues

Clinical liver disease

Hepatology (Baltimore, Md.)

Obesity science & practice

This page only lists publications with an associated author ORCID identifier.

Publications

Gres Karim, Megha Reddy, Navim Mobin, Ilan Weisberg, Amreen M Dinani
Immunosuppression management for refractory checkpoint inhibitor-related hepatotoxicity. Clinical liver disease 23 (1) (2024)
Gres Karim, Megha Reddy, Navim Mobin, Ilan Weisberg, Amreen M Dinani
Immunosuppression management for refractory checkpoint inhibitor-related hepatotoxicity. Clinical liver disease 23 (1) (2024)
Melissa Hershman, Karen Torbjornsen, Daniel Pang, Brooke Wyatt, Douglas T Dieterich, Ponni V Perumalswami, Andrea D Branch, Amreen M Dinani
Modification of the diabetes prevention program for the treatment of nonalcoholic fatty liver disease: A pilot study. Obesity science & practice 9 (3) (2022)
Amreen M Dinani, Kris V Kowdley, Mazen Noureddin
Application of Artificial Intelligence for Diagnosis and Risk Stratification in NAFLD and NASH: The State of the Art. Hepatology (Baltimore, Md.) 74 (4) (2021)